United Therapeutics Corp. (UTHR)
593.31
-2.35
(-0.39%)
USD |
NASDAQ |
Nov 12, 16:00
593.38
+0.07
(+0.01%)
After-Hours: 20:00
United Therapeutics Market Cap : 25.15B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 25.15B |
| November 11, 2026 | 25.25B |
| November 10, 2026 | 24.95B |
| November 09, 2026 | 24.69B |
| November 06, 2026 | 23.82B |
| November 05, 2026 | 23.98B |
| November 04, 2026 | 25.79B |
| November 03, 2026 | 25.49B |
| November 02, 2026 | 25.27B |
| October 30, 2026 | 25.55B |
| October 29, 2026 | 25.33B |
| October 28, 2026 | 25.03B |
| October 27, 2026 | 25.23B |
| October 26, 2026 | 25.30B |
| October 23, 2026 | 25.07B |
| October 22, 2026 | 24.96B |
| October 21, 2026 | 24.05B |
| October 20, 2026 | 23.64B |
| October 19, 2026 | 23.18B |
| October 16, 2026 | 22.75B |
| October 15, 2026 | 23.11B |
| October 14, 2026 | 23.05B |
| October 13, 2026 | 23.19B |
| October 12, 2026 | 23.48B |
| October 09, 2026 | 23.44B |
| Date | Value |
|---|---|
| October 08, 2026 | 22.74B |
| October 07, 2026 | 23.26B |
| October 06, 2026 | 23.11B |
| October 05, 2026 | 22.89B |
| October 02, 2026 | 23.12B |
| October 01, 2026 | 24.38B |
| September 30, 2026 | 23.13B |
| September 29, 2026 | 20.55B |
| September 28, 2026 | 20.72B |
| September 25, 2026 | 20.29B |
| September 24, 2026 | 20.15B |
| September 23, 2026 | 20.89B |
| September 22, 2026 | 21.24B |
| September 21, 2026 | 21.04B |
| September 18, 2026 | 21.11B |
| September 17, 2026 | 21.22B |
| September 16, 2026 | 21.27B |
| September 15, 2026 | 21.35B |
| September 14, 2026 | 21.45B |
| September 11, 2026 | 21.22B |
| September 10, 2026 | 21.50B |
| September 09, 2026 | 21.63B |
| September 08, 2026 | 21.25B |
| September 04, 2026 | 20.81B |
| September 03, 2026 | 20.92B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 5.215B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Exelixis, Inc. | 17.09B |
| Gilead Sciences, Inc. | 208.43B |
| Insmed, Inc. | 25.90B |
Market Cap Related Metrics
| PE Ratio | 22.38 |
| PS Ratio | 8.637 |
| PEG Ratio | 49.10 |
| Price to Book Value | 4.007 |
| Price to Free Cash Flow | 31.87 |
| Price | 593.31 |
| Earnings Yield | 4.47% |
| PEGY Ratio | 49.10 |
| Operating PE Ratio | 19.83 |
| Normalized PE Ratio | 23.32 |